Metronomic capecitabine in the advanced patients with hepatocellular carcinoma (HCC): Preliminary results

被引：0
|
作者：
Brandi, G.
Fanello, S.
Piscaglia, F.
Falanga, A.
Bolondi, L.
Flori, S.
Derenzini, E.
Palassini, E.
Fedele, M.
Biasco, G.
机构：
[1] St Orsola Malpighi Hosp, Bologna, Italy
[2] Riuniti Hosp, Bergamo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15163
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Preliminary results of metronomic capecitabine treatment in advanced hepatocellular carcinoma (HCC)
    Brandi, G.
    Fanello, S.
    Piscaglia, F.
    Falanga, A.
    Balducci, D.
    Pantaleo, M. A.
    Muscolo, P.
    Derenzini, E.
    Bolondi, L.
    Biasco, G.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 12 - 13
  • [2] Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study
    Brandi, Giovanni
    de Rosa, Francesco
    Agostini, Valentina
    di Girolamo, Stefania
    Andreone, Pietro
    Bolondi, Luigi
    Serra, Carla
    Sama, Claudia
    Golfieri, Rita
    Gramenzi, Annagiulia
    Cucchetti, Alessandro
    Pinna, Antonio Daniele
    Trevisani, Franco
    Biasco, Guido
    [J]. ONCOLOGIST, 2013, 18 (12): : 1256 - 1257
  • [3] EFFICACY AND TOXICITY OF METRONOMIC CAPECITABINE IN ADVANCED HEPATOCELLULAR CARCINOMA
    Farrag, A.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S391 - S391
  • [4] Role of metronomic capecitabine in advanced hepatocellular carcinoma.
    Mateen, Abdul
    Adil, Allah Rakha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine
    Kapacee, Zainul Abedin
    McNamara, Mairead G.
    Carino, Nicola de Liguori
    Lamarca, Angela
    Valle, Juan W.
    Hubner, Richard A.
    [J]. EJSO, 2021, 47 (08): : 2209 - 2210
  • [6] Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma
    Ballardini, Pierluigi
    Marri, Ivan
    Margutti, Guido
    Aliberti, Camillo
    Benea, Giorgio
    Manfredini, Roberto
    [J]. TUMORI JOURNAL, 2010, 96 (05): : 768 - 770
  • [7] Metronomic oral cyclophosphamide & low dose nivolumab for advanced hepatocellular carcinoma (HCC).
    Chen, Jo-Pai
    Kao, Tsui-Mai
    Hsueh, Fu-Jen
    Lu, Wei-Chen
    Ma, Wei-li
    Wu, Hsu
    Chiang, Keng-Man
    Chen, Hsing-wu
    Kuo, Sung-Hsin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] PHASE II STUDY OF EVEROLIMUS AND CAPECITABINE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC). RESULTS OF THE FIRST 10 PATIENTS INCLUDED
    Luelmo, S.
    Osanto, S.
    Weijl, N.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 256 - 257
  • [9] Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
    Brandi, Giovanni
    Venturi, Michela
    De Lorenzo, Stefania
    Garuti, Francesca
    Frega, Giorgio
    Palloni, Andrea
    Garajova, Ingrid
    Abbati, Francesca
    Saccoccio, Gioconda
    Golfieri, Rita
    Pantaleo, Maria Abbondanza
    Barbera, Maria Aurelia
    [J]. CANCER COMMUNICATIONS, 2018, 38
  • [10] Capecitabine in advanced hepatocellular carcinoma
    Murer, Francesca
    Pozzan, Caterina
    Peserico, Giulia
    Farinati, Fabio
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1260 - 1261
12345